HomeRYTM • NASDAQ
add
Rhythm Pharmaceuticals Inc
Previous close
$59.03
Day range
$59.00 - $60.25
Year range
$31.53 - $68.58
Market cap
3.68B USD
Avg Volume
572.76K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 33.25M | 47.76% |
Operating expense | 73.31M | 14.46% |
Net income | -43.64M | 1.18% |
Net profit margin | -131.25 | 33.12% |
Earnings per share | -0.73 | 3.95% |
EBITDA | -43.50M | 0.03% |
Effective tax rate | 0.78% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 298.39M | -0.29% |
Total assets | 363.57M | 2.65% |
Total liabilities | 210.88M | 34.55% |
Total equity | 152.70M | — |
Shares outstanding | 61.46M | — |
Price to book | 327.94 | — |
Return on assets | -29.44% | — |
Return on capital | -39.33% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -43.64M | 1.18% |
Cash from operations | -25.22M | 13.80% |
Cash from investing | -90.82M | 4.36% |
Cash from financing | 2.49M | -96.59% |
Net change in cash | -114.14M | -123.42% |
Free cash flow | 9.16M | 136.78% |
About
Founded
Nov 2008
Headquarters
Website
Employees
226
